GlassScriptPhysician profile
Tedi Vlahu
NPI 1326335928
$2,789.36
in general payments reported to CMS, 2019-2025
22 companies · $999 in 2025
The $999 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $162 · 2021: $555 · 2022: $22.12 · 2023: $611 · 2024: $225 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $985 · Consulting Fee: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.72 |
| Consulting Fee | $850.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Winter & Ibe Gmbh | $850.00 | 2025 | Endoeye Flex Deflectable Videoscope |
| Atricure, INC. | $676.92 | 2020-2024 | |
| Edwards Lifesciences Corporation | $273.87 | 2023-2025 | Sapien 3 Ultra Resilia, Mitris Resilia Mitral Valve |
| Bolton Medical INC | $150.06 | 2023 | Treo Abdominal Stent-Graft System |
| Abiomed | $137.60 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.09 | 2023-2024 | Lifevest |
| Medtronic Vascular, INC. | $94.71 | 2019 | |
| Chiesi USA, INC. | $81.81 | 2023-2025 | Cleviprex, Kengreal |
| Astrazeneca Pharmaceuticals LP | $53.12 | 2023-2025 | Fasenra, Tezspire |
| Ethicon US, LLC | $45.99 | 2019 | |
| Abbott Laboratories | $41.06 | 2019-2020 | |
| Baxter Healthcare | $34.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.95 | 2023 | |
| Lemaitre Vascular, INC. | $25.47 | 2023 | Restoreflow |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.36 | 2023 | Jardiance |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $22.63 | 2025 | Alphavac |
| Livanova USA, INC. | $22.12 | 2022 | |
| Zimmer Biomet Holdings, INC. | $20.64 | 2019 | |
| Mylan Specialty L.P. | $19.51 | 2024 | Yupelri |
| Terumo Medical Corporation | $18.67 | 2021 | |
| Lsi Solutions INC | $18.27 | 2024 | Cor-Knot |
| Kls-Martin L.P. | $15.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tedi Vlahu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.